share_log

西门子医疗扩建德国鲁多尔施塔特生产基地,用于生产瓦里安放疗设备核心部件

Siemens Healthcare expands production site in Rudolstadt, Germany to produce core components for Walian radiotherapy equipment

PR Newswire ·  Sep 7, 2023 02:00
  • A factory for manufacturing spare parts of radiotherapy equipment will be built.
  • The new plant is expected to start production in mid-2024.
  • Invest about 25 million euros to demonstrate a firm commitment to the Rudor Stadt factory.

Erlangen, September 7, 2023 / PRNewswire-Asianet /-- Siemens Medical recently announced the expansion of its production base in Rudolstadt, Germany. By mid-2024, a new production building will be built on the base. The new production building will produce electron accelerators for radiation sources of Siemens medical Varian cancer radiotherapy equipment. The building will also expand the production line of liquid metal plain bearings, which is the core technology of high-end computed tomography and angiography systems. Siemens Healthcare invested about 25 million euros to build the 2100-square-meter manufacturing plant. The new building will be built in a carbon-neutral manner and operated in a sustainable manner. Mr. Peter Schardt, Chief Technology Officer of Siemens Medical and head of Technology at Rudostadt, said: "this expansion demonstrates Siemens Medical's strong commitment to the Rudolstadt base and the region as a whole. We hope to continue to develop here, create more jobs and continue to be an attractive employer. "

In order to meet the growing market demand for Varian radiotherapy equipment, Siemens Medical needs to establish a second production base for core components of radiotherapy equipment outside Palo Alto in the United States. At Rudolstadt, Siemens Healthcare has the necessary knowledge reserves and has begun to produce such components. Electron accelerator components produced in Rudolstadt will be used in Varian Halcyon and TrueBeam radiotherapy systems, some of which will be manufactured at the Kemnath plant in Germany.

Using linear accelerator for radiotherapy is one of the most important means in modern cancer treatment, and it is currently used in more than half of the cancer treatments in the world. The linear accelerator can be used for tumor targeted treatment of outpatients and hospital patients.

Siemens Medical Rudolstadt factory was established in 1919. Today, approximately 270 employees develop and produce vacuum components, X-ray tubes and components for medical and industrial applications at the Rudolstadt plant. These components are used in computed tomography, angiography systems, or mammography equipment. The plant is also the manufacturing center of the industrial electronic linear accelerator system, which is mainly used for non-destructive material testing and scanning to check the contents of containers, trucks and train carriages.

About Siemens Medical

Siemens Medical (Frankfurt Stock Exchange: SHL), based in Erlangen, Germany, is a leading medical technology company dedicated to continuously developing a portfolio of products and services, including artificial intelligence-based applications and digital products that are playing an increasingly important role in the development of a new generation of medical technologies. These new applications will further consolidate the company's foundation in the areas of in vitro diagnosis, image-guided therapy, in vivo diagnosis and new cancer diagnosis and treatment. At the same time, Siemens Healthcare provides a wide range of services and solutions to help medical service providers enhance their capabilities and provide high-quality and efficient services for patients. In fiscal year 2022 (as of September 30, 2022), Siemens Healthcare had total revenue of 21.7 billion euros and approximately 69500 employees worldwide.

Innovative environment, for every life! For more information, please visit the official Siemens Medical website:

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment